Detalles de la búsqueda
1.
Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis.
Int J Mol Sci;
22(6)2021 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33802979
2.
Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
Am J Gastroenterol;
111(8): 1165-76, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27272011
3.
Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
Am J Gastroenterol;
107(3): 440-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22233694
4.
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.
Neurogastroenterol Motil;
34(10): e14390, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485994
5.
Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission.
Cell Mol Gastroenterol Hepatol;
12(4): 1415-1432, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34126236
6.
Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis.
Sci Rep;
11(1): 8641, 2021 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33883600
7.
The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis.
Inflammation;
43(2): 507-517, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797122
8.
T-cell activation in patients with irritable bowel syndrome.
Am J Gastroenterol;
104(5): 1205-12, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19367268
9.
Mucosal and Systemic Immune Profiles Differ During Early and Late Phases of the Disease in Patients With Active Ulcerative Colitis.
J Crohns Colitis;
13(11): 1450-1458, 2019 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30946450
10.
A pilot study of colonic B cell pattern in irritable bowel syndrome.
Scand J Gastroenterol;
43(12): 1461-6, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18663666
11.
The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
Inflamm Bowel Dis;
23(6): 956-966, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28445247
12.
Effects of Aloe barbadensis Mill. extract (AVH200®) on human blood T cell activity in vitro.
J Ethnopharmacol;
179: 301-9, 2016 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771068
13.
Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study.
United European Gastroenterol J;
3(1): 72-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25653861
14.
Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.
J Crohns Colitis;
9(1): 56-65, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25518051
15.
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.
J Crohns Colitis;
9(1): 26-32, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008478
16.
Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
J Crohns Colitis;
8(8): 789-95, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24418661
17.
Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis.
Inflamm Bowel Dis;
19(3): 576-81, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23377170
18.
Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
J Crohns Colitis;
7(12): e615-22, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23694857
19.
Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Inflamm Bowel Dis;
19(11): 2433-9, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23966065
20.
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis.
United European Gastroenterol J;
1(6): 467-76, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24917999